This paper highlights the current literature on the pathogenesis, risk factors, diagnosis and management of device related infections
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The use of implantable devices in management of cardiac diseases is increasing as a result of improvements in technology of permanent pace- maker and implantable cardioverter defibrillators.
📊
Key Findings & Data:Accurate diagnosis and optimal management of these infections is challenging, necessitating complete removal of the device and prolonged antibiotic therapy.
💡
Conclusion & Impact:This paper highlights the current literature on the pathogenesis, risk factors, diagnosis and management of device related infections
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The use of implantable devices in management of cardiac diseases is increasing as a result of improvements in technology of permanent pace- maker and implantable cardioverter defibrillators. Device related infections are also rising accordingly and have become an important clinical problem. Accurate diagnosis and optimal management of these infections is challenging, necessitating complete removal of the device and prolonged antibiotic therapy. In this regard, a multidisciplinary approach is required with the essential support of microbiology and imaging modalities. This paper highlights the current literature on the pathogenesis, risk factors, diagnosis and management of device related infections
🔖
Cite This Article
KAFES, H., GÜRAY, Y., GÜCÜK, E. İ. (2022). Management of cardiac device infections according to current data. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 1, 76–81. https://ajindex.com/articles/436010
Goldberger Z, Lampert R. Implantable cardioverter defibrillators:expanding indications and technologies. JAMA 2006
[CrossRef] 2. Ipek EG, Güray U, Demirkan B, Güray Y, Aksu T. Infections of implantable cardiac rhythm devices: predisposing factors and outcome. Acta Cardiol 2012
Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011
[CrossRef] 4. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007
[CrossRef] 5. Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012
[CrossRef] 6. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007
[CrossRef] 7. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007
[CrossRef] 8. Uslan DZ, Gleva MJ, Warren DK, Mela T, Chung MK, Gottipaty V, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol 2012
[CrossRef] 9. Johansen JB, Jorgensen OD, Moller M, Arnsbo P Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011
[CrossRef] 10. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001
[CrossRef] 11. Baddour LM, Epstein AE, Erickson CC, Knight BP Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010